Mutations in gliomas often occur in IDH1 and IDH2, both of which caused the conversion of α-ketoglutarate (α-KG) to 2-hydroxyglutarate (2-HG) in a NADPH-dependent manner (Waitkus et al., 2016). The gene discussed is IDH2; the disease is central nervous system cancer.